A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer
暂无分享，去创建一个
K. Zaman | R. Winterhalder | C. Mamot | U. Hasler-Strub | C. Rochlitz | A. Wicki | E. Obermann | A. Tzankov | K. Dedes | C. Ackermann | U. Novak | R. Ritschard | A. Bodmer | D. Bärtschi | Qiyu Li | L. Boos | C. Caspar | Ursina Zürrer-Härdi | S. Deuster | S. Riniker | R. von Moos | L. Holer | V. Membrez-Antonioli | Martin Senn | Lisa Holer